+36.1%
MRNA vs VEEV
+18.9%
+17.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VEEV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.5% | +4.8% | +5.1% |
| 7D | -1.1% | -4.6% | +3.5% | +1.3% |
| 30D | +126.1% | +8.6% | +117.5% | +116.2% |
| 3M | +190.0% | +62.4% | +127.6% | +136.0% |
| 6M | +157.2% | +40.3% | +117.0% | +120.3% |
| YTD | +388.2% | +17.5% | +370.7% | +350.5% |
| 1Y | +467.0% | -6.1% | +473.1% | +473.1% |
| 3Y | +36.1% | +16.7% | +19.4% | +14.2% |
| All | +36.1% | +18.9% | +17.1% | +14.2% |
Cumulative growth
Daily Returns
Daily percentage return beside VEEV.
Daily Out/Under-Performance
Portfolio return minus VEEV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VEEV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VEEV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling